SILODOSIN | A204726 | CHARTWELL RX SCIENCES LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2013-06-17 | Terminated 2017-04-13 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Watson Laboratories, Inc. - Citizen Petition FDA-2013-P-0574 · 3 docket documents Watson Laboratories, Inc. filed this citizen petition under sections 505 and 505(q) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA refuse to approve any ANDAs for generic versions of RAPAFLO (silodosin) capsules, including ANDA No. 204726 submitted by Sandoz Inc., unless applica | 505(q) | 2013-05-23 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.